Edeki T - Search Results

1

PhRMA white paper on ADME pharmacogenomics.

Williams JA, Andersson T, Andersson TB, Blanchard R, Behm MO, Cohen N, Edeki T, Franc M, Hillgren KM, Johnson KJ, Katz DA, Milton MN, Murray BP, Polli JW, Ricci D, Shipley LA, Vangala S, Wrighton SA. Williams JA, et al. Among authors: edeki t. J Clin Pharmacol. 2008 Jul;48(7):849-89. doi: 10.1177/0091270008319329. Epub 2008 Jun 4. J Clin Pharmacol. 2008. PMID: 18524998 Review.

2

International Transporter Consortium commentary on clinically important transporter polymorphisms.

Giacomini KM, Balimane PV, Cho SK, Eadon M, Edeki T, Hillgren KM, Huang SM, Sugiyama Y, Weitz D, Wen Y, Xia CQ, Yee SW, Zimdahl H, Niemi M; International Transporter Consortium. Giacomini KM, et al. Among authors: edeki t. Clin Pharmacol Ther. 2013 Jul;94(1):23-6. doi: 10.1038/clpt.2013.12. Clin Pharmacol Ther. 2013. PMID: 23778707

3

Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics.

Katz DA, Carr R, Grimm DR, Xiong H, Holley-Shanks R, Mueller T, Leake B, Wang Q, Han L, Wang PG, Edeki T, Sahelijo L, Doan T, Allen A, Spear BB, Kim RB. Katz DA, et al. Among authors: edeki t. Clin Pharmacol Ther. 2006 Mar;79(3):186-96. doi: 10.1016/j.clpt.2005.11.003. Epub 2006 Feb 17. Clin Pharmacol Ther. 2006. PMID: 16513443

4

PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.

Karara AH, Edeki T, McLeod J, Tonelli AP, Wagner JA. Karara AH, et al. Among authors: edeki t. J Clin Pharmacol. 2010 Apr;50(4):380-91. doi: 10.1177/0091270009344987. Epub 2010 Jan 23. J Clin Pharmacol. 2010. PMID: 20097935

5

Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects.

Gustavson LE, Schweitzer SM, Burt DA, Achari R, Rieser MJ, Edeki T, Chira T, Yannicelli HD, Kelly MT. Gustavson LE, et al. Among authors: edeki t. Clin Ther. 2006 Mar;28(3):373-87. doi: 10.1016/j.clinthera.2006.03.009. Clin Ther. 2006. PMID: 16750452 Clinical Trial.

6

A phase I multiple-dose escalation study characterizing pharmacokinetics and safety of ABT-578 in healthy subjects.

Karyekar CS, Pradhan RS, Freeney T, Ji Q, Edeki T, Chiu W, Awni WM, Locke C, Schwartz LB, Granneman RG, O'Dea R. Karyekar CS, et al. Among authors: edeki t. J Clin Pharmacol. 2005 Aug;45(8):910-8. doi: 10.1177/0091270005278807. J Clin Pharmacol. 2005. PMID: 16027401 Clinical Trial.

7

An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.

Edeki T, Johnston A, Turner P. Edeki T, et al. Eur J Clin Pharmacol. 1990;39(4):405-7. doi: 10.1007/BF00315420. Eur J Clin Pharmacol. 1990. PMID: 2076727

8

Induction of cyp3a in primary cultures of human hepatocytes by ginkgolides a and B.

He N, Cai HB, Xie HG, Collins X, Edeki TI, Strom SC. He N, et al. Clin Exp Pharmacol Physiol. 2007 Jul;34(7):632-5. doi: 10.1111/j.1440-1681.2007.04630.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17581220

9

Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam.

Das S, Armstrong J, Mathews D, Li J, Edeki T. Das S, et al. Among authors: edeki t. J Clin Pharmacol. 2014 Mar;54(3):331-40. doi: 10.1002/jcph.199. Epub 2013 Oct 22. J Clin Pharmacol. 2014. PMID: 24150927 Clinical Trial.

10

Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing.

Edeki T, Johnston A, Li Kam Wa E, Turner P. Edeki T, et al. Int J Clin Pharmacol Ther. 1994 Mar;32(3):142-6. Int J Clin Pharmacol Ther. 1994. PMID: 8205376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page